CN1192204A - 用作平滑肌细胞增殖抑制剂的2－取代苯并咪唑衍生物 - Google Patents

用作平滑肌细胞增殖抑制剂的2－取代苯并咪唑衍生物 Download PDF

Info

Publication number
CN1192204A
CN1192204A CN96195885A CN96195885A CN1192204A CN 1192204 A CN1192204 A CN 1192204A CN 96195885 A CN96195885 A CN 96195885A CN 96195885 A CN96195885 A CN 96195885A CN 1192204 A CN1192204 A CN 1192204A
Authority
CN
China
Prior art keywords
carbon atoms
compound
pharmaceutically acceptable
formula
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96195885A
Other languages
English (en)
Chinese (zh)
Inventor
H·M·艾罗达
C·西-伊尔
T·S·苏尔科斯基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of CN1192204A publication Critical patent/CN1192204A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN96195885A 1995-06-07 1996-06-03 用作平滑肌细胞增殖抑制剂的2－取代苯并咪唑衍生物 Pending CN1192204A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/477,842 1995-06-07
US08/477,842 US5654436A (en) 1995-06-07 1995-06-07 2-substituted benzimidazole derivatives

Publications (1)

Publication Number Publication Date
CN1192204A true CN1192204A (zh) 1998-09-02

Family

ID=23897571

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96195885A Pending CN1192204A (zh) 1995-06-07 1996-06-03 用作平滑肌细胞增殖抑制剂的2－取代苯并咪唑衍生物

Country Status (18)

Country Link
US (1) US5654436A (enExample)
EP (1) EP0830344B1 (enExample)
JP (1) JPH11506752A (enExample)
KR (1) KR19990022318A (enExample)
CN (1) CN1192204A (enExample)
AR (1) AR003129A1 (enExample)
AT (1) ATE209635T1 (enExample)
BR (1) BR9608557A (enExample)
CA (1) CA2223962A1 (enExample)
DE (1) DE69617420T2 (enExample)
ES (1) ES2165501T3 (enExample)
HU (1) HUP9900895A3 (enExample)
IL (1) IL118412A0 (enExample)
NZ (1) NZ309498A (enExample)
PT (1) PT830344E (enExample)
TW (1) TW322473B (enExample)
WO (1) WO1996040644A1 (enExample)
ZA (1) ZA964622B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990146A (en) * 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
AU2007230911A1 (en) * 2006-03-23 2007-10-04 Synta Pharmaceuticals Corp. Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
US8501957B2 (en) * 2008-12-10 2013-08-06 China Medical University Benzimidazole compounds and their use as anticancer agents
ES2624453T3 (es) * 2013-04-29 2017-07-14 F. Hoffmann-La Roche Ag Derivados de 2-fenil o 2-hetaril-imidazol[1,2-a]piridina

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2876233A (en) * 1956-10-29 1959-03-03 Gruenenthal Chemie 1-(p-halobenzyl)-2-methyl benzimidazoles and salts
FR1228524A (enExample) * 1958-05-23 1960-08-31
FR1530439A (fr) * 1966-05-16 1968-06-28 Pentachlorobenzyl-1 benzimidazoles
HU193951B (en) * 1985-03-11 1987-12-28 Richter Gedeon Vegyeszet Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
US5128359A (en) * 1990-02-16 1992-07-07 Laboratoires Upsa Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation
GB9027200D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
DE4212748A1 (de) * 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions

Also Published As

Publication number Publication date
AR003129A1 (es) 1998-07-08
HUP9900895A2 (hu) 1999-07-28
KR19990022318A (ko) 1999-03-25
ZA964622B (en) 1997-12-04
NZ309498A (en) 2000-09-29
WO1996040644A1 (en) 1996-12-19
EP0830344A1 (en) 1998-03-25
ES2165501T3 (es) 2002-03-16
EP0830344B1 (en) 2001-11-28
CA2223962A1 (en) 1996-12-19
PT830344E (pt) 2002-04-29
BR9608557A (pt) 1999-07-06
JPH11506752A (ja) 1999-06-15
AU697295B2 (en) 1998-10-01
TW322473B (enExample) 1997-12-11
DE69617420D1 (de) 2002-01-10
DE69617420T2 (de) 2002-05-02
MX9709650A (es) 1998-07-31
US5654436A (en) 1997-08-05
HUP9900895A3 (en) 2001-08-28
IL118412A0 (en) 1996-09-12
ATE209635T1 (de) 2001-12-15
AU5968396A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
CN110461846B (zh) 一类具有抑制并降解布鲁顿酪氨酸蛋白激酶Btk活性的化合物
EP0830345B1 (en) Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
CN1192204A (zh) 用作平滑肌细胞增殖抑制剂的2－取代苯并咪唑衍生物
CN1192207A (zh) 用作平滑肌细胞增殖抑制剂的2－取代苯并咪唑衍生物
MXPA97009465A (en) Derivatives of benzymidazole 2-substituted as inhibitors of the proliferation of musculol cells
US5763473A (en) Use of 2-substituted benzimidazole as smooth muscle cell proliferation inhibitors
CN1192205A (zh) 用作平滑肌细胞增殖抑制剂的苯并咪唑衍生物
AU697295C (en) 2-substituted benzimidazole derivatives as smooth muscle cell proliferation hibitors
EP0835244B1 (en) Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors
MXPA97009650A (en) Derivatives of benzymidazole 2-substituted as inhibitors of proliferation of muscle cells
MXPA97009647A (en) Derivatives of estirilbencimidazol as inhibitors of proliferation of muscle cells l
MXPA97009646A (en) Benzymidazole derivatives as proliferation inhibitors of muscle cells l

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication